Search research articles
Contact Us
Filters
Showing results (51-60 of 341) with videos related to
Page
of 35
Sort By:
Drugs
|
January 1, 1993
Design and rationale of a randomised comparison of cyclophosphamide, methotrexate and fluorouracil vs fluorouracil, epirubicin and cyclophosphamide in node-positive premenopausal women with operable breast cancer. A trial of the International Collaborative Cancer Group (ICCG)
J Wils, R C Coombes, M Marty, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1981
Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer
D P Dearnaley, S Patel, T J Powles, et al.
British Journal of Cancer
|
March 1, 1994
Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma
T R Evans, M G Rowlands, M Law, et al.
British Journal of Cancer
|
June 1, 1992
Absence of HPV 16 and 18 DNA in breast cancer
D Wrede, Y A Luqmani, R C Coombes, et al.
The Journal of Biological Chemistry
|
November 5, 1997
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha
P Pace, J Taylor, S Suntharalingam, et al.
Bioscience Reports
|
October 1, 1987
Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat
R C Coombes, N J Rothwell, P Shah, et al.
Journal of Steroid Biochemistry
|
February 1, 1986
Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat
P E Goss, M Jarman, J R Wilkinson, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 1, 1991
Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma
T R Evans, M G Rowlands, M Jarman, et al.
Cancer Treatment Reports
|
November 1, 1987
Oral gestrinone: a novel antiprogestin with no antitumor activity in endocrine-sensitive breast cancer
D Cunningham, J C Gazet, H T Ford, et al.
Cancer Treatment Reports
|
June 1, 1986
High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer
P E Goss, S Ashley, T J Powles, et al.
Page
of 35
Search research articles
Search
Showing results (51-60 of 341) with videos related to
Sort By:
Page
of 35
Drugs
|
January 1, 1993
Design and rationale of a randomised comparison of cyclophosphamide, methotrexate and fluorouracil vs fluorouracil, epirubicin and cyclophosphamide in node-positive premenopausal women with operable breast cancer. A trial of the International Collaborative Cancer Group (ICCG)
J Wils, R C Coombes, M Marty, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1981
Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer
D P Dearnaley, S Patel, T J Powles, et al.
British Journal of Cancer
|
March 1, 1994
Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma
T R Evans, M G Rowlands, M Law, et al.
British Journal of Cancer
|
June 1, 1992
Absence of HPV 16 and 18 DNA in breast cancer
D Wrede, Y A Luqmani, R C Coombes, et al.
The Journal of Biological Chemistry
|
November 5, 1997
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha
P Pace, J Taylor, S Suntharalingam, et al.
Bioscience Reports
|
October 1, 1987
Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat
R C Coombes, N J Rothwell, P Shah, et al.
Journal of Steroid Biochemistry
|
February 1, 1986
Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat
P E Goss, M Jarman, J R Wilkinson, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 1, 1991
Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma
T R Evans, M G Rowlands, M Jarman, et al.
Cancer Treatment Reports
|
November 1, 1987
Oral gestrinone: a novel antiprogestin with no antitumor activity in endocrine-sensitive breast cancer
D Cunningham, J C Gazet, H T Ford, et al.
Cancer Treatment Reports
|
June 1, 1986
High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer
P E Goss, S Ashley, T J Powles, et al.
Page
of 35